These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response. Madapura HS; Salamon D; Wiman KG; Lain S; Klein E; Nagy N Cell Cycle; 2016 May; 15(9):1267-75. PubMed ID: 26985633 [TBL] [Abstract][Full Text] [Related]
24. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53. Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149 [TBL] [Abstract][Full Text] [Related]
25. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692 [TBL] [Abstract][Full Text] [Related]
26. BAG2 is a target of the c-Myc gene and is involved in cellular senescence via the p21(CIP1) pathway. Zhang J; Lou X; Yang S; He S; Yang L; Liu M; Zhu H; Shan Q; Su S; Zhan Q; Xu N; Liu S Cancer Lett; 2012 May; 318(1):34-41. PubMed ID: 22146591 [TBL] [Abstract][Full Text] [Related]
27. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation. Dolnikov A; Millington M; Sun LQ; Symonds G Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291 [TBL] [Abstract][Full Text] [Related]
28. [Coordination inhibition of the proliferation of MCF-7 by enhancing expression of p53,p21 and decreasing expression of c-myc]. Zhang HJ; Wang N; Zhu XY; Sang JL; He DC Shi Yan Sheng Wu Xue Bao; 2005 Feb; 38(1):16-22. PubMed ID: 15839202 [TBL] [Abstract][Full Text] [Related]
29. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107 [TBL] [Abstract][Full Text] [Related]
30. Increased Δ133p53 mRNA in lung carcinoma corresponds with reduction of p21 expression. Fragou A; Tzimagiorgis G; Karageorgopoulos C; Barbetakis N; Lazopoulos A; Papaioannou M; Haitoglou C; Kouidou S Mol Med Rep; 2017 Apr; 15(4):1455-1460. PubMed ID: 28260096 [TBL] [Abstract][Full Text] [Related]
31. Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway. Fan Y; Jia X; Xie T; Zhu L; He F Oncol Rep; 2020 Dec; 44(6):2669-2677. PubMed ID: 33125136 [TBL] [Abstract][Full Text] [Related]
32. MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21. Liu L; Xu F; Chang CK; He Q; Wu LY; Zhang Z; Li X Cell Death Dis; 2017 Oct; 8(10):e3126. PubMed ID: 29022893 [TBL] [Abstract][Full Text] [Related]
33. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Mitchell KO; El-Deiry WS Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992 [TBL] [Abstract][Full Text] [Related]
35. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc. Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819 [TBL] [Abstract][Full Text] [Related]
36. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen. Masuo T; Okamura S; Zhang Y; Mori M Cancer Lett; 2009 Nov; 285(1):66-72. PubMed ID: 19481339 [TBL] [Abstract][Full Text] [Related]
37. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis. Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583 [TBL] [Abstract][Full Text] [Related]
38. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis. Feng T; Liu Y; Li C; Li Z; Cai H Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979 [TBL] [Abstract][Full Text] [Related]
39. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Seoane J; Le HV; Massagué J Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701 [TBL] [Abstract][Full Text] [Related]
40. BimEL-dependent apoptosis induced in peripheral blood lymphocytes with n-butyric acid is moderated by variation in expression of c-myc and p21(WAF1). Kalousek I; Brodska B; Otevrelova P; Röselova P Cell Biochem Funct; 2008 Jun; 26(4):509-21. PubMed ID: 18348176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]